Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Roldán, Nestor González
Zenclussen, Ana Claudia
von Stebut, Esther
MetadataShow full item record
AbstractMast cells (MC), well known for their effector functions in Th2 skewed allergic and also autoimmune inflammation, become increasingly acknowledged for their role in protection of health. It is now clear that they are also key modulators of immune responses at interface organs like skin or gut. MC can prime tissues for adequate inflammatory responses and cooperate with dendritic cells in T cell activation. They also regulate harmful immune responses in trauma and help to successfully orchestrate pregnancy. This review focusses on the beneficial effects of mast cells on tissue homeostasis and elimination of toxins or venoms. MC can enhance pathogen clearance in many bacterial, viral, and parasite infections, e.g. by TLR2 triggered degranulation, secretion of antimicrobial cathelicidins, recruiting neutrophils or by providing extracellular DNA traps. The role of MC in tumors is more ambiguous, however, encouraging new findings show they can change the tumor microenvironment towards anti-tumor immunity when adequately triggered. Uterine tissue remodeling by α-chymase (MCP-5) is crucial for successful embryo implantation. MCP-4 and the tryptase MCP-6 emerge to be protective in CNS trauma by reducing inflammatory damage and excessive scar formation, thereby protecting axon growth. Last but not least, we see proteases like carboxypeptidase A released by FcεRI activated MC detoxify an increasing number of venoms and endogenous toxins. A better understanding of the plasticity of MC will help to improve these advantageous effects, and hint on ways to cut down detrimental MC actions.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.; HIPS, Helmholtz-Institut füt Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
- Authors: Roy A, Ganesh G, Sippola H, Bolin S, Sawesi O, Dagälv A, Schlenner SM, Feyerabend T, Rodewald HR, Kjellén L, Hellman L, Åbrink M
- Issue date: 2014 Jan 3
- Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease.
- Authors: Owens EP, Vesey DA, Kassianos AJ, Healy H, Hoy WE, Gobe GC
- Issue date: 2019 May
- Antimicrobial Activity of Mast Cells: Role and Relevance of Extracellular DNA Traps.
- Authors: Möllerherm H, von Köckritz-Blickwede M, Branitzki-Heinemann K
- Issue date: 2016
- Retinoic Acid Negatively Impacts Proliferation and MC<sub>TC</sub> Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability.
- Authors: Babina M, Artuc M, Guhl S, Zuberbier T
- Issue date: 2017 Feb 28
- Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.
- Authors: Legere SA, Haidl ID, Légaré JF, Marshall JS
- Issue date: 2019